In early-stage mood disorder patients, we see that all PBMC are sensitive to NLRP3 activation, as evidenced by the significant increase in intracellular ASC specks and extracellular IL-1 beta production (Figure 3). This evidence concerns the gene NLRP3 and mood disorder.